Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes.
High-risk types of human papillomavirus (HPV), such as HPV16, have been found in nearly all cases of cervical cancer. Therapies targeted at blocking the HPV16 E6 protein and its deleterious effects on the tumour suppressor pathways of the cell can reverse the malignant phenotype of affected keratino...
Main Authors: | Melissa Togtema, Samuel Pichardo, Robert Jackson, Paul F Lambert, Laura Curiel, Ingeborg Zehbe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3511358?pdf=render |
Similar Items
-
Tumourigenesis driven by the human papillomavirus type 16 Asian-American e6 variant in a three-dimensional keratinocyte model.
by: Robert Jackson, et al.
Published: (2014-01-01) -
Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein
by: Melissa Togtema, et al.
Published: (2019-04-01) -
Virus–Host Protein–Protein Interactions between Human Papillomavirus 16 E6 A1 and D2/D3 Sub-Lineages: Variances and Similarities
by: Guillem Dayer, et al.
Published: (2020-10-01) -
High Intensity Focused Ultrasound Technology, its Scope and Applications in Therapy and Drug Delivery
by: Christopher Peter Phenix, et al.
Published: (2014-03-01) -
The effects of interferon-β upon cervical keratinocytes infected with human papillomavirus type 16
by: Herdman, Michael Trent
Published: (2006)